StockVS

NASDAQ · USD

Psyence Biomedical Ltd. (PBMWW) Stock Analysis

Psyence Biomedical Ltd. (PBMWW) is a stock listed on NASDAQ and quoted in US Dollar.

PBMWW

$0.03

+$0.00 (+9.32%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on Psyence Biomedical Ltd. (PBMW) common stock.

Issuer fundamentals are shown on the issuer page, not here.

Price History

Hover for the daily close. The dotted line marks the period open.

PBMWW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.02
Previous Close
$0.02
Day's Range
0.02–0.03
52-Week Range
0.02–0.03
Volume
51.59K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.73

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PBMWW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+68.63%
2025 (partial year)+0.00%

As of September 4, 2026.

About Psyence Biomedical Ltd.

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.

Visit website →